Stem Cells: New Hope For Spinal Cord Injury
Stem cell therapy offers several attractive strategies for spinal cord repair. The regenerative potential of pluripotent stem cells was confirmed in an animal model of Spinal Cord Injury (SCI); nevertheless, optimized growth and differentiation protocols along with reliable safety assays should be e...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2015-03-01
|
Series: | Serbian Journal of Experimental and Clinical Research |
Online Access: | https://doi.org/10.1515/sjecr-2015-0001 |
id |
doaj-11d3375a22c146d0a0ecec7a642bd937 |
---|---|
record_format |
Article |
spelling |
doaj-11d3375a22c146d0a0ecec7a642bd9372021-09-05T14:00:37ZengSciendoSerbian Journal of Experimental and Clinical Research 1820-86652335-075X2015-03-011613810.1515/sjecr-2015-0001sjecr-2015-0001Stem Cells: New Hope For Spinal Cord InjuryGazdic Marina0Volarevic Vladislav1Stojkovic Miodrag2 Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Serbia Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Serbia Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, SerbiaStem cell therapy offers several attractive strategies for spinal cord repair. The regenerative potential of pluripotent stem cells was confirmed in an animal model of Spinal Cord Injury (SCI); nevertheless, optimized growth and differentiation protocols along with reliable safety assays should be established prior to the clinical application of hESCs and iPSCs. Th e therapeutic effects of mesenchymal stem cells (MSCs) in SCI result from neurotrophin secretion, angiogenesis, and antiinflammatory actions. Several preclinical SCI studies have reported that the occurrence of axonal extension, remyelination and neuroprotection occur after the transplantation of olfactory ensheathing cells (OECs). The transplantation of neural stem cells NSCs (NSCs) promotes partial functional improvement after SCI because of their potential to differentiate into neurons, oligodendrocytes, and astrocytes. The ideal source of stem cells for safe and efficient cell-based therapy for SCI remains a challenging issue that requires further investigation.https://doi.org/10.1515/sjecr-2015-0001 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gazdic Marina Volarevic Vladislav Stojkovic Miodrag |
spellingShingle |
Gazdic Marina Volarevic Vladislav Stojkovic Miodrag Stem Cells: New Hope For Spinal Cord Injury Serbian Journal of Experimental and Clinical Research |
author_facet |
Gazdic Marina Volarevic Vladislav Stojkovic Miodrag |
author_sort |
Gazdic Marina |
title |
Stem Cells: New Hope For Spinal Cord Injury |
title_short |
Stem Cells: New Hope For Spinal Cord Injury |
title_full |
Stem Cells: New Hope For Spinal Cord Injury |
title_fullStr |
Stem Cells: New Hope For Spinal Cord Injury |
title_full_unstemmed |
Stem Cells: New Hope For Spinal Cord Injury |
title_sort |
stem cells: new hope for spinal cord injury |
publisher |
Sciendo |
series |
Serbian Journal of Experimental and Clinical Research |
issn |
1820-8665 2335-075X |
publishDate |
2015-03-01 |
description |
Stem cell therapy offers several attractive strategies for spinal cord repair. The regenerative potential of pluripotent stem cells was confirmed in an animal model of Spinal Cord Injury (SCI); nevertheless, optimized growth and differentiation protocols along with reliable safety assays should be established prior to the clinical application of hESCs and iPSCs. Th e therapeutic effects of mesenchymal stem cells (MSCs) in SCI result from neurotrophin secretion, angiogenesis, and antiinflammatory actions. Several preclinical SCI studies have reported that the occurrence of axonal extension, remyelination and neuroprotection occur after the transplantation of olfactory ensheathing cells (OECs). The transplantation of neural stem cells NSCs (NSCs) promotes partial functional improvement after SCI because of their potential to differentiate into neurons, oligodendrocytes, and astrocytes. The ideal source of stem cells for safe and efficient cell-based therapy for SCI remains a challenging issue that requires further investigation. |
url |
https://doi.org/10.1515/sjecr-2015-0001 |
work_keys_str_mv |
AT gazdicmarina stemcellsnewhopeforspinalcordinjury AT volarevicvladislav stemcellsnewhopeforspinalcordinjury AT stojkovicmiodrag stemcellsnewhopeforspinalcordinjury |
_version_ |
1717811596283084800 |